国际肿瘤学杂志

国际肿瘤学杂志 ›› 2015, Vol. 42 ›› Issue (3): 228-231.doi: 10.3760/cma.j.issn.1673422X.2015.03.018

• 综述 • 上一篇    下一篇

结直肠癌肝转移的治疗进展

郭晓静,曹妮达,陶丽,顾缨,朱莹杰,郑坚   

  1. 200032上海中医药大学附属龙华医院肿瘤科
  • 出版日期:2015-03-08 发布日期:2015-01-29
  • 基金资助:

    上海市卫生局青年科研项目（20134y141）

The current treatment progress of colorectal cancer with liver metastases

Guo Xiaojing, Cao Nida, Tao Li, Gu Ying, Zhu Yingjie, Zheng Jian   

  1. Department of Oncology， Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine， Shanghai 200032， China
  • Online:2015-03-08 Published:2015-01-29
  • Contact: Zheng Jian E-mail:zzf725@sina.com

PDF

1841

摘要： 多学科综合治疗结直肠癌肝转移已成为临床研究的热点，其包含了手术治疗、局部治疗、转化治疗、化疗及分子靶向药物治疗等措施。然而，在临床应用中，常需要多种治疗方法联合使用，并根据患者病情制定全程治疗策略方能使患者生存获益最大化。因此，明确目前临床常用治疗方法的最新研究进展对临床治疗选择十分重要。

关键词: 结直肠肿瘤, 肿瘤转移, 外科手术, 分子靶向药物

Abstract: The multidisciplinary synthetic therapy for the colorectal liver metastases has been a hot spot in clinical research, which includes operative therapy, tumor local therapy, conversion therapy, chemotherapy, molecular targeted therapy and so on. It is need to choose multiple therapies for the patients and make the whole treatment strategy in accordance with the condition of patients to maximize the survival benefit in clinical practice. So, it is important to comprehend the newest research process of the clinical therapy to make a good choice for the colorectal liver metastases patients.

Key words: Colorectal neoplasms, Neoplasm metastasis, Surgical procedures, operative, Molecular targeted therapy